Biolife Solutions (BLFS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2008 | 12-2007 | 12-2006 | 12-2005 | 12-2004 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 99 | 57 | 310 | 185 | 532 |
| Receivables | 279 | 301 | 99 | 76 | 75 |
| Inventories | 625 | 99 | 93 | 123 | 94 |
| TOTAL | $1,023 | $570 | $516 | $385 | $704 |
| Non-Current Assets | |||||
| PPE Net | 130 | 113 | 45 | 62 | 129 |
| Other Non-Current Assets | 18 | 44 | 0 | 0 | 0 |
| TOTAL | $148 | $156 | $45 | $62 | $129 |
| Total Assets | $1,171 | $726 | $560 | $447 | $833 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 659 | 97 | 90 | 66 | 85 |
| Accrued Expenses | 242 | 340 | 93 | 117 | 135 |
| TOTAL | $927 | $446 | $380 | $211 | $220 |
| Non-Current Liabilities | |||||
| Long Term Debt | 5,063 | 2,750 | N/A | 198 | N/A |
| Deferred Revenues | 26 | 8 | N/A | N/A | N/A |
| aiOther Non-Current Liabilities | 279 | 0 | 0 | 0 | 0 |
| TOTAL | $5,415 | $2,750 | $N/A | $198 | $N/A |
| Total Liabilities | $6,342 | $3,196 | $380 | $409 | $220 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4,972 | 4,970 | 4,970 | 886 | 886 |
| Common Shares | 70 | 70 | 69 | 12 | 12 |
| Retained earnings | -47,443 | -44,668 | -41,816 | -40,682 | -40,063 |
| Other shareholders' equity | 0 | 0 | -9 | -31 | 0 |
| TOTAL | $-5,171 | $-2,470 | $180 | $39 | $613 |
| Total Liabilities And Equity | $1,171 | $726 | $560 | $447 | $833 |